Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

403
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
403
Exercise and Muscle Performance01:27

Exercise and Muscle Performance

4.4K
Exercise induces a range of adaptations in muscle tissue, depending on the type and duration of activity. Such physical training can be broadly categorized into two types: endurance exercises and resistance exercises.
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
4.4K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

216
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
216
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

259
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
259
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

340
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
340
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

347
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Some Physiological and Biochemical Indices in Patients with Covid-19 Pneumonia Using Mathematical Methods.

Journal of evolutionary biochemistry and physiology·2021
Same author

Effects of drugs on exercise performance.

Bulletin of experimental biology and medicine·2013
Same author

[Biological effects of electromagnetic radiation of extremely high frequencies combined with physiologically active compounds].

Radiatsionnaia biologiia, radioecologiia·2008
Same author

[The influence of the 1-(2'-hydroxiethyl)-2-methyl-5-nitroimidazole on the state of erythrocyte membranes and their models].

Biomeditsinskaia khimiia·2006
Same author

[Nonspecific effect of morphine on the erythrocyte membrane].

Biofizika·2004
Same author

[The respiratory activity of Rhodococcus rhodochrous M8 cells producing nitrile-hydrolyzing enzymes].

Prikladnaia biokhimiia i mikrobiologiia·2001

Related Experiment Video

Updated: Mar 29, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.5K

Pharmaceutical Composition for Improving Physical Working Capacity.

S I Baulin1, S M Rogacheva1, S V Afanaseva1

  • 1Yu. A. Gagarin Saratov State Technological University, Saratov, Russia.

Bulletin of Experimental Biology and Medicine
|November 26, 2015
PubMed
Summary
This summary is machine-generated.

This study found a three-component pharmaceutical composition significantly improved physical performance in rats. The optimal blend of asparcam, mildronate, and metaprotein showed no adverse effects on blood markers.

Keywords:
forced swimming testlaboratory animalspharmaceutical compositionphysical performance

More Related Videos

Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
07:26

Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans

Published on: October 17, 2018

21.6K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.3K

Related Experiment Videos

Last Updated: Mar 29, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.5K
Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
07:26

Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans

Published on: October 17, 2018

21.6K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.3K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Animal Physiology

Background:

  • Physical performance enhancement is a key area in pharmaceutical research.
  • Understanding the synergistic effects of drug combinations is crucial for developing effective performance-enhancing agents.

Purpose of the Study:

  • To evaluate the efficacy of various drugs and their combinations in improving physical performance using the forced swimming test.
  • To identify an optimal composition for enhancing physical endurance.

Main Methods:

  • Laboratory rats were used to test the effects of different drug combinations on performance in the forced swimming test.
  • Biochemical and morphological analyses of blood serum and peripheral blood were conducted.

Main Results:

  • A three-component composition of asparcam, mildronate, and metaprotein at specific proportions (5.0, 10.7, and 14.3 mg/kg) demonstrated the maximum improvement in forced swimming test performance.
  • Single intragastric administration of this composition did not result in significant changes in blood serum biochemistry or peripheral blood morphology.

Conclusions:

  • The identified three-component composition is a promising candidate for pharmaceutical development aimed at improving physical performance.
  • The composition appears safe for single-dose administration, showing no detectable negative impact on key blood parameters.